Disclosure Panels Details Page
Bladder/Penile Cancers Panel - Disclosures as of 05/15/2018
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Neeraj Agarwal MD | None | Argos Therapeutics Clovis Eisai Inc. EMD Serono Exelixis Inc. Merck & Co., Inc. Novartis Pharmaceuticals Corporation Pfizer Inc. |
None | None | - |
| Rick Bangs MBA, PMP | Open vs. Robotic Cystectomy (last meeting on 10/21/2016) -- no commercial interest | None | None | None | ✔ |
| Marian Birkeland PhD | None | None | None | None | - |
| Stephen Boorjian MD | Canadian randomized trial of tranexamic acid use during cystectomy FKD |
None | None | None | ✔ |
| Mark Buyyounouski MD, MS | None | None | None | None | ✔ |
| Sarah DeVincenzo PharmD, BCPS | None | Decision Resources Group Consulting | None | None | - |
| Tracy Downs MD | Dendreon Corporation Photocure |
None | None | None | - |
| Mary Dwyer MS | None | None | None | None | ✔ |
| Jason Efstathiou MD, DPhil | Bayer HealthCare | BlueEarth Diagnostics Pfizer Inc. Taris Biomedical |
None | None | ✔ |
| Thomas Flaig MD | Agensys, Inc. Astellas Pharma US, Inc. AstraZeneca Pharmaceuticals LP Eli Lilly and Company Genentech, Inc. Seattle Genetics, Inc. |
None | None | None | ✔ |
| Terence Friedlander MD | AstraZeneca Pharmaceuticals LP Genentech, Inc. GlaxoSmithKline Janssen Pharmaceutica Products, LP |
Clovis Oncology Genentech, Inc. Pfizer Inc. |
Astellas Pharma US, Inc. EMD Serono sanofi-aventis U.S. |
MedBioGene | ✔ |
| Richard Greenberg MD, FACS | None | None | None | None | ✔ |
| Kristina Gregory MSN, RN, OCN | None | None | None | None | ✔ |
| Lisa Gurski PhD | None | None | None | None | ✔ |
| Khurshid Guru MD | None | None | None | None | - |
| Noah Hahn MD | Acerta Pharma AstraZeneca Pharmaceuticals LP Bristol-Myers Squibb Company Genentech, Inc. Heat Biologics Inovio Pharmaceutcals Merck & Co., Inc. Mirati Novartis Pharmaceuticals Corporation Oncogenex Principia Biopharma |
AstraZeneca Pharmaceuticals LP Champions Oncology Genentech, Inc. Health Advances Incyte Inovio Pharmaceuticals Merck & Co., Inc. Pieris Pharmaceuticals Rexahn Seattle Genetics TARIS Biomedical TransMed |
None | None | ✔ |
| Evelyn Handel PharmD, BCOP, BCPS | None | None | None | None | - |
| Harry Herr MD | None | None | None | None | ✔ |
| Christopher Hoimes MD | Altor Bioscience Astellas Pharma US, Inc. AstraZeneca Pharmaceuticals LP Johnson & Johnson MedImmune Inc. Merck & Co., Inc. Millennium Pharmaceuticals, Inc. Novartis Pharmaceuticals Corporation OncoGenex Roche Laboratories, Inc. SeattleGenetics |
Foundation Medicine Seattle Genetics |
Bristol-Myers Squibb Company Genentech, Inc. |
None | - |
| Brant Inman MD, MSc | Abbott Laboratories Celsion Combat medical Dendreon Corporation FKD therapeutics Genentech, Inc. Nucleix Urogen |
Biocancell | None | None | ✔ |
| Masahito Jimbo MD, PhD, MPH | None | None | None | None | ✔ |
| Alyse Johnson-Chilla MS | None | None | None | None | ✔ |
| A. Karim Kader PhD | Olympus Pelfucure |
Pellficure | None | SNP Bio Inc | - |
| Ann Karosas RPh, BCOP | None | None | None | None | ✔ |
| Subodh Lele MD | None | None | None | None | ✔ |
| Joan McClure MS | None | None | None | None | ✔ |
| Joshua Meeks MD, PhD | Merck & Co., Inc. | None | None | None | ✔ |
| Jeff Michalski MD, MBA | National Cancer Institute | None | None | None | ✔ |
| Jeffrey Montgomery MD, MHSA | None | None | None | None | ✔ |
| Lance Pagliaro MD | Genentech, Inc. Pfizer Inc. |
Merck & Co., Inc. | None | None | ✔ |
| Sumanta Pal MD | Acceleron Pharma, Inc. | Astellas Pharma US, Inc. Bristol-Myers Squibb Company Exelixis Inc. Genentech, Inc. Ipsen Novartis Pharmaceuticals Corporation Pfizer Inc. |
Astellas Pharma US, Inc. Genentech, Inc. |
None | - |
| Anthony Patterson MD | None | None | None | None | ✔ |
| Elizabeth Plimack MD, MS | None | AstraZeneca Pharmaceuticals LP Bristol-Myers Squibb Company Clovis Exelixis Inc. Genentech, Inc. Horizon Pharma Inovio Merck & Co., Inc. |
None | None | ✔ |
| Kamal Pohar MD | None | None | None | None | ✔ |
| Michael Porter MD, MS | None | None | None | None | ✔ |
| Donna Powell DHSc, CMD, RT(T) | None | None | None | None | ✔ |
| Mark Preston MD, MPH | None | None | None | None | ✔ |
| Wade Sexton MD | None | expert witness | None | None | ✔ |
| Arlene Siefker-Radtke MD | Janssen Pharmaceutica Products, LP Millennium Pharmaceuticals, Inc. |
AstraZeneca Pharmaceuticals LP Bristol-Myers Squibb Company Eisai Inc. EMD Serono Genentech, Inc. Inovio Pharmaceuticals Janssen Pharmaceutica Products, LP Merck & Co., Inc. |
None | None | - |
| Jack Skinner PhD | None | None | None | None | ✔ |
| Philippe Spiess MD, MS, FACS, FRCS | None | Genentech, Inc. Pfizer Inc. |
None | None | ✔ |
| Amy Tuten PharmD, BCOP | None | None | None | None | ✔ |
| Jonathan Tward MD, PhD | None | Dendreon Corporation Myriad Genetic Laboratories, Inc. |
None | None | - |
| Geoffrey Wile MD | None | None | None | None | ✔ |